Basal Insulin Peglispro Demonstrates Preferential Hepatic vs. Peripheral Action Relative to Insulin Glargine in Healthy Subjects

被引：0
|
作者：
Henry, Robert R.
Mudaliar, Sunder
Choi, Siak Leng
Ciaraldi, Theodore P.
Armstrong, Debra A.
Pettus, Jeremy
Garhyan, Parag
Knadler, Mary P.
Jacober, Scott J.
Lam, Eric Chen Quin
Linnebjerg, Helle
Porksen, Niels
Prince, Melvin J.
Sinha, Vikram P.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
886-P
引用
收藏
页码：A226 / A226
页数：1
相关论文
共 50 条
  • [1] Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
    Henry, Robert R.
    Mudaliar, Sunder
    Ciaraldi, Theodore P.
    Armstrong, Debra A.
    Burke, Paivi
    Pettus, Jeremy
    Garhyan, Parag
    Choi, Siak Leng
    Jacober, Scott J.
    Knadler, Mary Pat
    Lam, Eric Chen Quin
    Prince, Melvin J.
    Bose, Namrata
    Porksen, Niels
    Sinha, Vikram P.
    Linnebjerg, Helle
    DIABETES CARE, 2014, 37 (09) : 2609 - 2615
  • [2] Basal Insulin peglispro (BIL) demonstrates hepato-preferential action vs insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Mudaliar, S.
    Henry, R. R.
    Ciaraldi, T. P.
    Armstrong, D. A.
    Burke, P. M.
    Pettus, J. H.
    Garhyan, P.
    Choi, S. L.
    Jacober, S. J.
    Knadler, M. P.
    Lam, E. C. Q.
    Prince, M. J.
    Bose, N.
    Porksen, N. K.
    Linnebjerg, H.
    DIABETOLOGIA, 2015, 58 : S1 - S1
  • [3] Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes
    Mudaliar, S.
    Henry, R. R.
    Ciaraldi, T. P.
    Armstrong, D. A.
    Burke, P. M.
    Pettus, J. H.
    Garhyan, P.
    Choi, S. L.
    Knadler, M. P.
    Lam, E. C. Q.
    Prince, M. J.
    Bose, N.
    Porksen, N. K.
    Sinha, V. P.
    Linnebjerg, H.
    Jacober, S. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 : 17 - 24
  • [4] Similar Counterregulatory Hormone Responses to Hypoglycemia with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in Type 1 Diabetes
    Heise, Tim
    Kapitza, Christoph
    Nosek, Leszek
    Lam, Eric Chen Quin
    Choi, Siak Leng
    Garhyan, Parag
    Jacober, Scott J.
    Porksen, Niels
    Prince, Melvin J.
    Linnebjerg, Helle
    DIABETES, 2015, 64 : A252 - A253
  • [5] The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
    Orchard, Trevor J.
    Cariou, Bertrand
    Connelly, Margery A.
    Otvos, James D.
    Zhang, Shuyu
    Antalis, Caryl J.
    Ivanyi, Tibor
    Hoogwerf, Byron J.
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [6] The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
    Trevor J. Orchard
    Bertrand Cariou
    Margery A. Connelly
    James D. Otvos
    Shuyu Zhang
    Caryl J. Antalis
    Tibor Ivanyi
    Byron J. Hoogwerf
    Cardiovascular Diabetology, 16
  • [7] Glycemic Variability with Dulaglutide vs. Basal Insulin Glargine
    Jodar, Esteban
    Romera, Irene
    Wang, Qianqian
    Caveda, Elena
    Emilio Garcia, Luis
    DIABETES, 2020, 69
  • [8] Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action
    Jacober, S. J.
    Prince, M. J.
    Beals, J. M.
    Hartman, M. L.
    Qu, Y.
    Linnebjerg, H.
    Garhyan, P.
    Haupt, A.
    DIABETES OBESITY & METABOLISM, 2016, 18 : 3 - 16
  • [9] A single dose pharmacokinetic study of basal insulin peglispro in subjects with hepatic impairment
    Choi, S. L.
    Loghin, C.
    Garhyan, P.
    Knadler, M. P.
    Lam, E.
    Sinha, V.
    Porksen, N.
    Linnebjerg, H.
    DIABETOLOGIA, 2014, 57 : S392 - S392
  • [10] Lipid Changes during 26-Wk Treatment with the Novel Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) or Insulin NPH in 6 IMAGINE Trials
    Ginsberg, Henry
    Cariou, Bertrand
    Orchard, Trevor J.
    Chen, Lei
    Luo, Junxiang
    Bastyr, Edward J., III
    Bue-Valleskey, Juliana
    Chang, Annette M.
    Ivanyi, Tibor
    Jacober, Scott J.
    Jacobson, Jennie G.
    Hoogwerf, Byron J.
    DIABETES, 2015, 64 : A251 - A251
12345